from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2783c/gpsI

LFCtreatmentdescriptionclass of inhibitor

-0.808

Amikacinug/mL Amikacintranslation

-0.582

Cap5-10ug/mL Capreomycintranslation

-0.275

Rox10-50 ug/mL Roxithromycintranslation

0.948

SM2-5 ug/mL Streptomycintranslation

-0.959

Tet5-10 ug/mL Tetracyclinetranslation

-0.091

Rif0.2-5ug/mL Rifampicintranscription

-0.215

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.071

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.820

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.535

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.226

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.268

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.981

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.915

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.235

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.698

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.873

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.229

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.282

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.385

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.051

KCN5-20 ug/mL Potassium cyaniderespiration

-0.036

NaN30.2-2 mM Sodium aziderespiration

0.434

Nigericin50 uM Nigericinrespiration

-0.633

TRC10-150 ug/mL Triclosanrespiration

-0.857

TRZ10-25 ug/mL Thioridazinerespiration

0.663

Valinomycin0.5-10 uM Valinomycinrespiration

-1.132

ZnSO42 mM ZnSO4respiration

0.179

menadione6-10 ug/mL Menadionerespiration

-0.058

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.016

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.158

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.102

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.091

NRP_1Non-replicating persistence stage 1dosRassociated

0.735

Amp0.2mg/mL AmpicillincellWall

0.717

Cephalexin20-100 ug/mL CephalexincellWall

-0.260

Cerulenin0.32-5 ug/mL CerulenincellWall

1.056

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.391

EMB10-20 ug/mL EthambutolcellWall

-0.374

Eta12-40 ug/mL EthionamidecellWall

0.017

INH0.2-0.4 ug/mL IsoniazidcellWall

0.072

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.202

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.365

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.489

BZA0.12 mg/mL BenzamidearomaticAmides

0.468

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.580

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.158

H2O24 mM hydrogen peroxideDNAdamaging

0.007

Levo10 ug/mL LevofloxacinDNAdamaging

0.339

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.214

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.335

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.546

UVUV-irradiationDNAdamaging

-0.638

ARP41-4 ug/mL Antitubercular compound ARP4?

0.305

Antimycin12.5-50 ug/mL Antimycin A?

-0.167

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.553

PA_110-50 ug/mL Antitubercular compound PA-1?

0.374

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.422

PA8240.2-2 ug/mL PA-824?

0.876

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.860

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.110

Verapamil50 uM Verapamil?

0.138

mercaptoethanol2 mM 2-Mercaptoethanol?

0.124

methoxatin10-20 ug/mL Methoxatin?